Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.
about
Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerThe discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceProfile of V. Craig JordanCardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast GroupIncreased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production.Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050).Recruitment of representative samples for low incidence cancer populations: do registries deliver?The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulatorsFrom adjuvant therapy to breast cancer prevention: BCPT and STAR.Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.Selective estrogen receptor modulators: tissue selectivity and differential uterine effects.Fulvestrant (Faslodex): current status in the therapy of breast cancer.Benefits and adverse effects of endocrine therapyFatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.Breast cancer chemoprevention: risk-benefit effects of the antioestrogen tamoxifen.Endometrial evaluation by ultrasonography, hysteroscopy and histopathology in cases of breast carcinoma on Tamoxifen therapy.Aromatase inhibitors in the treatment of early and advanced breast cancer.Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancerLetrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids.A phase I trial to assess the pharmacology of the new oestrogen receptor antagonist fulvestrant on the endometrium in healthy postmenopausal volunteersDevelopment and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.Breast cancer of the older woman: an annotated review.Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.Putting the cardiovascular safety of aromatase inhibitors in patients with early breast cancer into perspective: a systematic review of the literature.Adjuvant therapy of node-negative breast cancer.Estrogen-replacement therapy after breast cancer. Risks versus benefits.An overview of considerations for the testing of tamoxifen as a preventive for breast cancer.Plasma proteomics analysis of tamoxifen resistance in breast cancer.Coronary heart disease mortality and adjuvant tamoxifen therapy.Hormonal chemoprevention of cancer in women.The 4Ps of Breast Cancer Chemoprevention: Putting Proven Principles into Practice.The scope of nutrition intervention trials with cancer-related endpoints.New Hormonal Therapies for Breast Cancer.Management of Menopausal Symptoms in Breast Cancer Patients
P2860
Q24685693-7B162DA0-7E93-4CEC-B851-2869950900B6Q26830744-A9D0729F-B3AC-4E6B-9BBC-C631B23A77F2Q28253151-5D535D26-03BC-4C15-8034-46969CEF035CQ28367785-F9E3EA2B-B460-4D42-ABCF-434DDC1BD170Q30423459-A83BBBE4-B9DC-499C-BB38-1AA436918D8DQ32043226-427CB789-A0F8-4AE9-8755-030FE836E3F2Q33793645-14B61417-69A9-4BE1-A0F5-3762F02DFCE6Q34315816-D9054829-1A10-4462-8F27-1F4EE756F730Q34317586-27E33A14-702A-493B-B4AA-353D2B8158CFQ34490225-D246CA6E-6B2B-4DEE-AD56-C66758C85D22Q34575198-7881B2D8-3051-4893-8693-A12755DDB2C1Q34734508-90C2A3F8-68DE-4EF1-A4D7-23D139872140Q35135718-52ED27F6-F0F0-4BC5-85E8-8D397B4B1251Q35180289-1F63F5C4-07F7-4E9E-8D67-9C2F01953746Q35194482-802120AE-B8CF-4497-9517-EC389F5797C7Q35785095-2C8DB9AB-F52F-4FF3-9EC6-63393EE96311Q36105220-B498F368-05B0-405F-9740-920B01D5E84FQ36115270-C69A0621-343D-41E9-B31A-4C42324D6AACQ36135542-3BB72B5F-F7DF-4CE4-BA86-5E724886ADC8Q36352053-C1A621CB-6CBB-4288-93E4-F9BEFD1FB67EQ36598699-E9AD219F-A7AA-47E0-83FE-33AC8892B027Q36612045-A705ADC2-00AA-4F59-A401-896F3092BCB6Q36646485-E7639CBC-CCF0-4821-A792-CFBEA407DAC1Q36684234-329FE1FD-A33A-4EEF-80E3-FBD56A53139BQ36695459-FD842728-FB28-4241-8076-0BFFCCEB01ADQ36832390-AAC6863C-4ABA-4B78-AAE1-1ED3FAF191BCQ37292414-32D4D8B3-37B4-4D25-85CA-14BDAEC7FDA5Q37955223-2887A3C8-42E5-4E9C-9030-AE58FEFD2427Q40441763-3DF0F54F-63DA-4D4D-BCD3-9A98B9189AC0Q40881393-EF2CE609-E335-47BD-B9A0-7D0BF2B5F47FQ40925446-FF4B5A81-7E2C-4A29-9234-0DF180370AE1Q44493749-12236ECC-8EE0-4E01-8D08-2CB69AC070D4Q44758234-93724B6E-2FE1-438A-B2F9-B5230152F7C6Q46728895-27335CBB-C197-4E36-B164-A74F18528BFBQ49370321-2B70D6BB-7691-4C58-B4AE-07719C3F36A7Q51592998-A10F3018-D36E-4BBA-BB8E-B2063D89E826Q54056103-FE3D2FDB-0D38-4B12-8CA1-64C7EE82322AQ58136310-9FB30252-07E6-4CA3-9E61-CB8F5BD211B4
P2860
Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Effects of tamoxifen therapy o ...... h node-negative breast cancer.
@en
Effects of tamoxifen therapy o ...... h node-negative breast cancer.
@nl
type
label
Effects of tamoxifen therapy o ...... h node-negative breast cancer.
@en
Effects of tamoxifen therapy o ...... h node-negative breast cancer.
@nl
prefLabel
Effects of tamoxifen therapy o ...... h node-negative breast cancer.
@en
Effects of tamoxifen therapy o ...... h node-negative breast cancer.
@nl
P2093
P356
P1476
Effects of tamoxifen therapy o ...... h node-negative breast cancer.
@en
P2093
Carbone PP
Newcomb PA
Surawicz TS
P304
P356
10.1093/JNCI/82.16.1327
P407
P577
1990-08-01T00:00:00Z